MILANO VINCENT — SEC Form 4 filings
SEC reporting owner CIK 1187159. 19 Form 4 filings on record with FilingPulse; latest filed 2026-09-02.
Transaction summary — filings shown
Covers all 19 filings on record, filed 2024-03-04 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 15,000 shares, $93,750 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 29.
- Largest priced transaction: purchase of 15,000 shares @ $6.25 ($93,750) in BIOCRYST PHARMACEUTICALS INC, filed 2024-05-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | 15 | 1 leg · 15,000 sh · $93,750 | — | 17 |
| Aclaris Therapeutics, Inc. (ACRS) | Director | 4 | — | — | 12 |
Form 4 filings — MILANO VINCENT
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-02 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 1,159 @ $9.70 | EDGAR |
| 2026-06-15 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 15,294 @ $0 · Grant/award (A): 33,540 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 11,580 · Grant/award (A): 42,350 (derivative) @ $0 · Grant/award (A): 10,987 (derivative) @ $0 · Option exercise (M): 11,580 (derivative) @ $0 | EDGAR |
| 2026-06-02 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 1,122 @ $8.91 | EDGAR |
| 2026-03-03 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 848 @ $8.75 | EDGAR |
| 2025-12-02 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 783 @ $7.18 | EDGAR |
| 2025-09-03 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 676 @ $8.31 | EDGAR |
| 2025-06-16 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 12,500 @ $0 · Grant/award (A): 27,181 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 4,793 · Grant/award (A): 42,350 (derivative) @ $0 · Grant/award (A): 11,580 (derivative) @ $0 · Option exercise (M): 4,793 (derivative) @ $0 | EDGAR |
| 2025-06-03 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 523 @ $10.75 | EDGAR |
| 2025-03-04 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 653 @ $8.61 | EDGAR |
| 2024-12-02 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 750 @ $7.50 | EDGAR |
| 2024-09-03 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 647 @ $8.69 | EDGAR |
| 2024-06-14 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 6,820 @ $0 · Grant/award (A): 49,933 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Grant/award (A): 15,750 (derivative) @ $0 · Grant/award (A): 4,793 (derivative) @ $0 | EDGAR |
| 2024-06-04 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 4,660 · Option exercise (M): 4,660 (derivative) @ $0 | EDGAR |
| 2024-06-03 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 870 @ $6.46 | EDGAR |
| 2024-05-22 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Purchase (P): 15,000 @ $6.25 | EDGAR |
| 2024-03-04 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 999 @ $5.63 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1187159 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →